The co-primary effectiveness endpoints were included in an intent-to-treat, multiple imputation (ITT-MI) analysis of change in body weight from baseline to Day 171.Margin of 3% of the percent total body weight loss for the Plenity arm compared to the placebo arm More than 35% of subjects ...
Response to "Unclear Benefit of Gelesis100 for Body Weight Loss" A majority of people (59%) treated with Gelesis100 were responders (> 5% weight loss [WL]), and 27% were super-responders (> 10% WL)... FL Greenway - 《Obesity》 ...
Abstract #989896: Plenity Treatment In The Gelesis Loss of Weight (GLOW) Study Is Associated With Improvement In Liver Health, As Measured By The NAFLD Fibrosis Scoredoi:10.1016/j.eprac.2021.04.630Christopher D. StillElaine ChiquetteBryan Jones...
分类名称Ingested, Transient, Space Occupying Device For Weight Management And/Or Weight Loss 产品分类码QFQ 申请企业Gelesis, Inc. 申请企业/联系人Eyal Ron 申请企业/街道1501 Boylston Street, Suite 6102 申请企业/城市Boston 申请企业/州MA 申请企业/国家代码US ...